2026 TREATMENTS

RESEARCH TITLE PRIMARY AUTHORS

Cheng, Hui (National Institute Communication Disorders)

Mesenchymal Cell Therapy in Osteogenesis Imperfecta (OI)

Emory Univ ersity

Bioethical challenges in postwar development aid: The Rwandan case study.

Wiktor Ł et al.

SUN-718 Results From A Phase 1, Open-label, Ascending Multiple-dose Study To Evaluate Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Romosozumab In Children And Adolescents With Osteogenesis Imperfecta And Phase 3 Study Rationale

P-20 EARLY ZOLEDRONIC ACID TREATMENT IN A PEDIATRIC CASE OF OSTEOGENESIS IMPERFECTA TYPE V: CLINICAL OUTCOMES AND THE ROLE OF IFITM5 (BRIL) MUTATION

On mobility and gait in scoliosis patients: a comparison of conventional and 3D-printed braces during an instrumented timed-up and go test.

Costantini S et al.

Registry-Based Frequency of Molecularly Confirmed Osteogenesis Imperfecta in a Swiss Cohort of Individuals With OI

Abegglen O et al.

The role of heat shock proteins in fracture healing-a narrative review.

Trieb K et al.

Viridicatol from the Deep-Sea-Derived Fungus Alleviates Bone Loss by Targeting the Wnt/SHN3 Pathway.

Xie CL et al.

Research Progress of Bone Grafting: A Comprehensive Review.

Zhang J et al.

Retrograde femoral nailing for deformity correction and fracture treatment in osteogenesis imperfecta: clinical and radiological assessment of a novel technique.

Georges S et al.

Correction to: Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study.

Engineered patient-derived organotypic bone model for multimodal characterization of donor-specific response to therapy

de Leeuw A et al.

Plates for the treatment of long bone metaphyseal and diaphyseal fracture and deformity in osteogenesis imperfecta: A scoping review.

Louni Y et al.

[A case of pamidronate disodium in the treatment of calvarial doughnut lesions with bone fragility in children].

Zhang DD et al.

A Systematic Review on the Efficacy of Bisphosphonates on Osteogenesis Imperfecta.

Datir RR et al.

Anti-transforming growth factor-β treatment shows increased bone mass and strength in a novel mouse model for osteogenesis imperfecta type I.

Busschers E et al.

Medial Patellofemoral Ligament Reconstruction in Osteogenesis Imperfecta Using Modified Basket-Weave Technique: A Case Report.

Fano AN et al.

An iMSC-Based iPSC Model for Osteogenesis Imperfecta: A Platform for Disease Modeling and Drug Screening

Kumar A et al.

Assessment of Bone Density in Osteogenesis Imperfecta in Pediatric and Adolescent Age Group: Can the Metacarpal Index

Play a Role?

Madhuri V et al.

A Scoping Review of Trainees With Motor and Sensory Disabilities in Surgical Specialties: Barriers, Representation, and Inclusive Solutions.

Kabir R et al.

Mechanistic investigation into Frizzled-2 signaling for treatment of Osteogenesis Imperfecta

Adeyeye, Mary Ifeoluwa (Unive Houston)

Clinical and Functional Outcomes of Telescoping Intramedullary Nails in Pediatric Osteogenesis Imperfecta: A Multicenter Prospective Study With a One-Year Follow-Up.

Tayyab M et al.

Urinary calcium and bone resorption markers during 3 years of denosumab treatment in pediatric osteogenesis imperfecta.

Stasek S et al.

Hip to Be Rare: The Intersection of Transient Osteoporosis and Osteogenesis Imperfecta.

Garzone A et al.

Jain C et al.

Tips and Tricks for Installation of the SLIM Nail in Osteogenesis Imperfecta with Narrow Medullary Canals: A Surgical Guide with Case Insights.

Mounsef PJ et al.

Preliminary high-dose irradiation of the recipient and associated damage of bone marrow stromal compartment enables bone marrow stroma transplantation.

Bigildeev A et al.

The Role of Osteoblasts in Phenotypic Variability of Dominant Osteogenesis Imperfecta: Evidence from Patients and Murine Models.

Jovanovic M et al.

Retrospective study on the outcomes of Fassier-Duval nailing and osteotomy for the treatment of long bone fractures or deformities in the lower extremities in children with osteogenesis imperfecta.

Jin B et al.

Use of Analgesics in Osteogenesis Imperfecta in Denmark-A Nationwide Register-based Cohort Study.

Horn CG et al.

Matrix-directed therapy losartan to identify the effect on the bone resorption marker carboxy-terminal crosslink of type I collagen telopeptide (CTX) in older adolescents and adults with

Haji Sadeghi M et al.

[Comprehensive considerations for the diagnosis, treatment, and management of osteogenesis imperfecta].

Lyu XH et al.

Altering host microenvironment is critical for success of cell therapy for osteogenesis imperfecta

Novak S et al.

Magnetically Controlled Intramedullary Compression Nailing for Femoral Nonunion in Osteogenesis Imperfecta: A Case Report.

Nahm NJ et al.

Biologics for bone regeneration: advances in cell, protein, gene, and mRNA therapies.

Del Toro Runzer C et al.

In Individuals with Osteogenesis Imperfecta, Cephalometric Findings Suggest that Bisphosphonate Therapy May Improve Craniofacial Growth.

Tuurala H et al.

The Metacarpophalangeal Pattern Profile: An Old Method With New Insights Into the Evaluation of Short Stature.

Maruichi MD et al.

Cellular Therapy for Osteogenesis Imperfecta

Kalajzic, Ivo (University Of Con

An Interventional Study to Evaluate the Impact of Blood Flow Restriction Training on Muscle, Bone, and Quality of Life in Adults With Osteogenesis Imperfecta Type I

University Hospital, Ghent

Comprehensive investigation of SP7 during the osteoblast-to- osteocyte transition

Wang, Jialiang (Ut Southweste

Can Telemedicine Support the Management of Osteogenesis Imperfecta?

Costa PHMMV et al.

Management of Osteogenesis Imperfecta Complicated by Severe Pneumonia in a Resource-Limited Setting: A Case Report.

Shah BK et al.

Clinical and Genetic Characterization of Osteogenesis Imperfecta in Japanese Patients: Outcomes of Sequential Bisphosphonate Therapy.

Yamada C et al.

Bone fragility persists in long-term bisphosphonate-treated oim mice despite sex-specific changes in bone quality.

Muñoz A et al.

Combined treatment with a C-type natriuretic peptide analog and bisphosphonate enhances bone growth in growing mice with osteogenesis imperfecta: a pilot study.

Mulcrone JE et al.

Transcriptomic and proteomic analysis of osteogenesis imperfecta disease-specific induced pluripotent stem cells.